Serveur d'exploration MERS - Checkpoint (Istex)

Index « Titre (en) » - entrée « hiv »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
hits < hiv < hivenv  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000065 (2016) Satoshi Tanamura [Japon] ; Hiroto Terakado [Japon] ; Kazuo Harada [Japon]Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer–RRE stem II complex
000159 (2014) Elena S. Odintsova [Russie] ; Pavel S. Dmitrenok [Russie] ; Anna M. Timofeeva [Russie] ; Valentina N. Buneva [Russie] ; Georgy A. Nevinsky [Russie]Why specific anti‐integrase antibodies from HIV‐infected patients can efficiently hydrolyze 21‐mer oligopeptide corresponding to antigenic determinant of human myelin basic protein
000265 (2013) Nathalie Goudreau [Canada] ; René Coulombe [Canada] ; Anne-Marie Faucher [Canada] ; Chantal Grand-Maître [Canada] ; Jean-Eric Lacoste [Canada] ; Christopher T. Lemke [Canada] ; Eric Malenfant [Canada] ; Yves Bousquet [Canada] ; Lee Fader [Canada] ; Bruno Simoneau [Canada] ; Jean-François Mercier [Canada] ; Steve Titolo [Canada] ; Stephen W. Mason [Canada, États-Unis]Monitoring Binding of HIV‐1 Capsid Assembly Inhibitors Using 19F Ligand‐and 15N Protein‐Based NMR and X‐ray Crystallography: Early Hit Validation of a Benzodiazepine Series
000337 (2012) S. D. Allard [Belgique] ; A. L. De Goede [Pays-Bas] ; B. De Keersmaecker [Belgique] ; C. Heirman [Belgique] ; P. Lacor [Belgique] ; A. D. M. E. Osterhaus [Pays-Bas] ; C. Demanet [Belgique] ; K. Thielemans [Belgique] ; R. A. Gruters [Pays-Bas] ; J. L. Aerts [Belgique]Sequence evolution and escape from specific immune pressure of an HIV‐1 Rev epitope with extensive sequence similarity to human nucleolar protein 6
000343 (2012) Jagadish Chandrabose Sundaramurthi [Inde] ; Soumya Swaminathan [Inde] ; Luke Elizabeth Hanna [Inde]Resistance-associated epitopes of HIV-1C—highly probable candidates for a multi-epitope vaccine
000347 (2012) Matthew T. Weinstock [États-Unis] ; J. Nicholas Francis [États-Unis] ; Joseph S. Redman [États-Unis] ; Michael S. Kay [États-Unis]Protease‐resistant peptide design—empowering nature's fragile warriors against HIV
000378 (2012) A. V. Serbin [Russie] ; A. V. Veselovskii [Russie] ; V. B. Tsvetkov [Russie]In vitro and in silico investigation of interferonogenic analogues of nucleic acids, artificially programmed to block the initial stages of HIV infection of cells
000436 (2011) Marta De Zotti [Italie] ; Wim De Borggraeve [Belgique] ; Bernard Kaptein [Pays-Bas] ; Quirinus B. Broxterman [Pays-Bas] ; Sheo B. Singh [États-Unis] ; Peter J. Felock [États-Unis] ; Daria J. Hazuda [États-Unis] ; Fernando Formaggio [Italie] ; Claudio Toniolo [Italie]Triple Hyp→Pro replacement in integramide A, a peptaib inhibitor of HIV‐1 integrase: Effect on conformation and bioactivity
000459 (2011) Susan Moir [États-Unis] ; Angela Malaspina [États-Unis] ; Anthony S. Fauci [États-Unis]Prospects for an HIV vaccine: leading B cells down the right path
000460 (2011) Yuanyuan Xiao [États-Unis] ; Mark R. Segal [États-Unis]Prediction of Genomewide Conserved Epitope Profiles of HIV-1: Classifier Choice and Peptide Representation
000462 (2011) E. O. Baranova [Russie] ; N. S. Shastina [Russie] ; V. I. Shvets [Russie]Polyanionic inhibitors of HIV adsorption
000473 (2011) Jennifer L. Kelschenbach [États-Unis] ; Manisha Saini [États-Unis] ; Eran Hadas [États-Unis] ; Chao-Jiang Gu [États-Unis] ; Wei Chao [États-Unis, Niger] ; Galina Bentsman [États-Unis] ; Jessie P. Hong [Royaume-Uni] ; Tomas Hanke [Royaume-Uni] ; Leroy R. Sharer [États-Unis] ; Mary Jane Potash [États-Unis] ; David J. Volsky [États-Unis]Mice Chronically Infected with Chimeric HIV Resist Peripheral and Brain Superinfection: A Model of Protective Immunity to HIV
000485 (2011) M. Yaghoobi [Canada] ; S. Le Gouvello ; N. Aloulou ; C. Duprez- Dutreuil ; F. Walker [France] ; I. SobhaniFoxP3 overexpression and CD1a+ and CD3+ depletion in anal tissue as possible mechanisms for increased risk of human papillomavirus‐related anal carcinoma in HIV infection
000683 (2009) Lynn Pulliam [États-Unis]HIV Regulation of Amyloid Beta Production
000763 (2008) Supriya D. Mahajan [États-Unis] ; Ravikumar Aalinkeel [États-Unis] ; Donald E. Sykes [États-Unis] ; Jessica L. Reynolds [États-Unis] ; B. Bindukumar [États-Unis] ; Stanley F. Fernandez [États-Unis] ; Ramnik Chawda [États-Unis] ; Thomas C. Shanahan [États-Unis] ; Stanley A. Schwartz [États-Unis]Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood–Brain Barrier Permeability
000793 (2008) Gopala Rishna Darbha ; Uma Shanker Rai ; Anant Umar Singh ; Paresh Handra Ray [États-Unis]Gold‐Nanorod‐Based Sensing of Sequence Specific HIV‐1 Virus DNA by Using Hyper‐Rayleigh Scattering Spectroscopy
000814 (2008) Alexander Berchanski [Israël] ; Aviva Lapidot [Israël]Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites
000A30 (2006) Gabriela Ivanova [Royaume-Uni] ; Andrey A. Arzumanov [Royaume-Uni] ; John J. Turner [Royaume-Uni] ; Sandrine Reigadas [France] ; Jean-Jacques Toulmé [France] ; Douglas E. Brown [Royaume-Uni] ; Andrew M. L. Lever [Royaume-Uni] ; Michael J. Gait [Royaume-Uni]Anti‐HIV Activity of Steric Block Oligonucleotides
000C04 (2004) Jane Gamberg [Canada] ; Lisa Barrett [Canada] ; Ian Bowmer [Canada] ; Constance Howley [Canada] ; Michael Grant [Canada]Immune Reconstitution and Viral Stimulation Are Required to Restore HIV-Specific CD8 T Cell Responses Following Advanced Infection
000C73 (2003) Monica Borgatti [Italie] ; Cristina Rutigliano [Italie] ; Nicoletta Bianchi [Italie] ; Carlo Mischiati [Italie] ; Pier Giovanni Baraldi [Italie] ; Romeo Romagnoli [Italie] ; Roberto Gambari [Italie]Inhibition of NF‐kB/DNA Interactions and HIV‐1 LTR Directed Transcription by Hybrid Molecules Containing Pyrrolo [2,1‐c] [1,4] Benzodiazepine (PBD) and Oligopyrrole Carriers
000E31 (2001) Pavel A. Ivanov [Russie] ; Eugene I. Lewitin [Russie] ; Boris I. Shevelev [Russie] ; Gleb V. Fominov [Russie] ; Jana A Wojciechowska [Russie] ; Ali H. Asadi Mobarhan [Russie] ; Yuri V. Vertiev [Russie] ; Nick K. Yankovsky [Russie] ; A. B Shevelev [Russie]Sup35p yeast prion-like protein as an adapter for production of the Gag-p55 antigen of HIV-1 and the L-chain of botulinum neurotoxin in Saccharomyces cerevisiae

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "hiv" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "hiv" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    hiv
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021